FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I (March 27)

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I (March 27)

FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I (March 27)
Mon, 30 Mar 2009 09:24:00 -0500

Medtronic, Inc. announced that the U.S. Food and Drug Administration classified as Class I its voluntary recall action initiated on February 11, 2009 of its BioGlide Ventricular Snap Shunt Catheter (Cat. numbers 27782, 27708 and 27802) -- the cerebral ventricular catheter component of a shunt for the treatment of hydrocephalus.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420